scAAV1.tMCK.NTF3: Clinical Trials

1 trial of scAAV1.tMCK.NTF3, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 withdrawn. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Withdrawn 1
Phase 21Withdrawn 1

Follow scAAV1.tMCK.NTF3: new trials by email Literature Review of scAAV1.tMCK.NTF3 trials Research Report on scAAV1.tMCK.NTF3

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase I/IIa Trial of scAAV1.tMCK.NTF3 for Treatment of CMT1A
scAAV1.tMCK.NTF3 - Charcot-Marie-Tooth Neuropathy Type 1A
Phase 1 / Phase 2WithdrawnNationwide Children's Hospital2027-04-012026-07-29

Conditions studied

Charcot-Marie-Tooth Disease (1)

Sponsors

Nationwide Children's Hospital (1)

Countries

United States (1)

Top investigators

Zarife Sahenk, MD., PhD. (1)